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Abstract
Background: Individual family planning service delivery organisations currently rely on service provision data and
couple-years of protection as health impact measures. Due to the substitution effect and the continuation of users
of long-term methods, these metrics cannot estimate an organisation’s contribution to the national modern
contraceptive prevalence rate (CPR), the standard metric for measuring family planning programme impacts.
Increasing CPR is essential for addressing the unmet need for family planning, a recognized global health priority.
Current health impact estimation models cannot isolate the impact of an organisation in these efforts. Marie
Stopes International designed the Impact 2 model to measure an organisation’s contribution to increases in
national CPR, as well as resulting health and demographic impacts. This paper aims to describe the methodology
for modelling increasing national-level CPR as well as to discuss its benefits and limitations.
Methods: Impact 2 converts service provision data into estimates of the number of family planning users,
accounting for continuation among users of long-term methods and addressing the challenges of converting
commodity distribution data of short-term methods into user numbers. These estimates, combined with the client
profile and data on the organisation’s previous year’s CPR contribution, enable Impact 2 to estimate which clients
maintain an organisation’s baseline contribution, which ones fulfil population growth offsets, and ultimately, which
ones increase CPR.
Results: Illustrative results from Marie Stopes Madagascar show how Impact 2 can be used to estimate an
organisation’s contribution to national changes in the CPR.
Conclusions: Impact 2 is a useful tool for service delivery organisations to move beyond cruder output measures
to a better understanding of their role in meeting the global unmet need for family planning. By considering
health impact from the perspective of an individual organisation, Impact 2 addresses gaps not met by other
models for family planning service outcomes. Further, the model helps organisations improve service delivery by
demonstrating that increases in the national CPR are not simply about expanding user numbers; rather, the type of
user (e.g. adopters, provider changers) must be considered. Impact 2 can be downloaded at http://www.
mariestopes.org/impact-2.
Background
An estimated 222 million women in developing coun-
tries have an unmet need for modern contraceptives [1].
This deficit puts women at risk of unintended pregnan-
cies, which can result in unsafe abortions or even
maternal death. Such a high level of unmet need under-
scores the pressing global health problem of access to
modern contraceptive services, an issue the wider repro-
ductive health and donor community has recognised
and prioritised. Recently, the July 2012 Family Planning
Summit announced a commitment to reach 120 million
additional women in the world’s poorest countries with* Correspondence: michelle.weinberger@mariestopes.org
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family planning services, in order to reduce the number
of unintended pregnancies and improve maternal and
child health [2]. Key benchmarks for global health also
recognise this unmet need. Increasing contraceptive use
is one of the chief indicators of Millennium Develop-
ment Goal 5 which aims to improve maternal health [3].
Similarly, the Department for International Develop-
ment’s Framework for Results for improving reproduc-
tive, maternal, and newborn health monitors the
number of additional modern family planning users
reached, with the aim of creating at least 10 million
more users by 2015 [4].
The modern contraceptive prevalence rate (CPR), a
figure that represents the proportion of women of
reproductive age (WRA) (15-49 years) using modern
methods of contraception, serves as the key metric for
measuring contraceptive uptake in the developing world
[3]. To increase CPR, family planning programmes must
augment the proportion of WRA using modern contra-
ception, in addition to maintaining contraceptive use
among existing family planning users. The modern CPR
is comprised of women using short-term methods, such
as oral contraceptive pills, condoms, and injectables, and
long-acting and permanent methods (LAPMs), such as
intrauterine devices (IUDs), implants, and sterilisation.
Ultimately, increases in CPR will be achieved through
the joint efforts of a wide range of actors across the
family planning sector and healthcare systems of devel-
oping countries, including public and private providers,
product distributors, and family planning advocates.
Marie Stopes International (MSI), a United Kingdom-
based, international non-governmental organisation,
plays a key role in these efforts. Operating in 42 countries
throughout the world, MSI’s extensive network of clinics,
outreach teams, and social franchises strengthens health
systems through its delivery of high-quality reproductive
health services to underserved women, with an emphasis
on clinic and provider capacity-building, modern contra-
ceptive choice, and quality assurance. As part of its rigor-
ous programme monitoring, the organisation places a
priority on understanding its contribution towards the
global goal of achieving universal access to contraception
[5]. However, as discussed below, attributing national
level increases in CPR to a single organisation - using a
metric called “increasing CPR” - is inherently difficult
due to two key challenges.
Both challenges derive from the metrics that service
delivery organisations typically use to measure pro-
gramme achievement. Most of these organisations track
programme progress through their service delivery out-
puts, such as the number of commodities and services
provided. Organisations also use couple-years of protec-
tion (CYPs), a metric that weights each family planning
method according to its effectiveness and the duration of
protection against pregnancy that the method provides to
the couple. For example, one 10-year IUD equates to 4.6
CYPs, a figure based on the IUD’s average duration of
use, while one contraceptive pill cycle provides 1/15th of
a CYP, since 15 pill cycles are needed for a full year of
protection [6]. To derive the total number of CYPs gen-
erated by a programme in a year, service provision data
by method distribution are multiplied by each of these
factors. While service delivery outputs and CYPs are use-
ful for understanding the scale of family planning pro-
grammes, they do not measure how these organisations
contribute towards increasing CPR. As a result, service
delivery outputs and CYPs cannot demonstrate an orga-
nisation’s national level health impact.
The main reason these metrics do not translate into
national-level impact is the substitution of clients. Some
clients who are new to a service delivery organisation
are actually not new to family planning; rather, they pre-
viously received contraceptives from a different provider.
Therefore, these clients’ move to the new provider can
increase an individual service delivery organisation’s ser-
vice and CYP numbers without having any effect on
increasing CPR (Figure 1). A study in Honduras demon-
strates this substitution effect, finding that increased
sales of a new, socially-marketed oral contraceptive pill
had no impact on national levels of contraceptive use;
prior users were simply substituting their former contra-
ceptives for the new brand [7].
Even if substitution could be addressed, using service
outputs and CYPs to demonstrate an organisation’s
national impact presents another challenge. In order to
determine any increase in modern CPR at the national
level, the number of women using family planning in a
given year needs to be estimated, a figure not indicated
by annual service provision data and the resulting CYPs.
This estimated number is more comprehensive than the
number of family planning clients served in a given year
because it takes LAPM clients from past years into
account. Since LAPMs offer multiple years of coverage,
women will continue to use these methods in years when
they did not receive services. While formulas for CYPs
acknowledge that LAPMs are used for multiple years,
this metric sums together all of the future years of use
for a method without defining the time period. For exam-
ple, a programme generating 1,000 CYPs in 2012 could
realise all of these in 2012 if they provide short-term
methods alone, or the programme could produce the
same number of CYPs over the next 10 years through the
provision of certain LAPMs. Therefore, CYPs cannot be
‘annualised’ to produce an estimate of the number of
women protected from pregnancy in a given year. To
determine an organisation’s impact on national CPR,
contraceptive use within a year needs to be isolated, pro-
ducing an estimate that includes the number of users
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served during that year along with the number of users
continuing to use LAPMs received in previous years.
Several models already exist that examine the relation-
ship between family planning services, CPR, and wider
health outcomes. Most notably, the FamPlan module of
the Spectrum modelling system [8] and the Realty √ [9]
model demonstrate how projected changes in CPR result
in different fertility rates, allowing estimations of changes
in other health conditions, such as the number of unin-
tended pregnancies, unsafe abortions, or maternal deaths.
Unfortunately, while these models can be used to show
the impact of CPR increases on reductions in national bur-
dens of these conditions, they do not cater to the unique
needs of service delivery organisations. These models can-
not estimate an organisation’s individual contribution to
increasing CPR, which accounts for the substitution effect.
Moreover, these existing models cannot transform service
provision data into increasing CPR by modelling estimates
of the number of family planning users in a given year.
Therefore, the national health impact of an organisation’s
family planning programme cannot be determined.
To fill these gaps, MSI has designed the Impact 2 model.
This model is a tool that programme managers can use to
easily and robustly estimate the impact of service provi-
sion, either past or future, on increasing national CPR.
Impact 2 estimates the total number of family planning
users in a given year, and what proportion of these users
counts towards an organisation’s contribution to increas-
ing CPR among all women, or in-union women as speci-
fied by the user (fuchsia boxes, Figure 2 below). In doing
so, the model considers the aforementioned challenges of
how to account for the continuation of LAPM clients and
the substitution effect. The Impact 2 model has wide uses
beyond this function, enabling an organisation to estimate
its impact using higher-level health, demographic, and
economic metrics such as unintended pregnancies averted,
maternal deaths averted, and disability-adjusted life years
(DALYs) averted (blue boxes, Figure 2).
This paper describes the methodology behind the first
level of the Impact 2 model, showing how service provi-
sion data can be translated into modelled user numbers
and ultimately, the key model output at its top level: an
organisation’s estimated percentage point contribution to
increasing the modern CPR. Following the model descrip-
tion, a demonstration of the model’s outputs is presented,
along with a discussion of the model’s benefits and limita-
tions. The methodology for calculating higher-level mater-
nal and child health metrics offered by Impact 2 is not
covered in this paper.
Methods
Model overview
Impact 2 is designed to convert an organisation’s service
delivery data, i.e. the number of services provided or
commodities distributed to clients, into a range of results,
including increasing CPR. First, these data are used to
determine estimates of the number of women served by
an organisation who are using a family planning method
during a certain year. To derive these estimates, different
modelling procedures are used for users of long-term
and short-term methods due to different characteristics
of the methods. Then, the model divides these estimated
Figure 1 Illustration of substitution effect on service provider’s contribution to CPR. In this example, an organisation draws additional
users from women already using contraception from other sources (light blue). Therefore, even though the organisation saw an increase in its
user numbers (growth in dark blue section), there was no net effect on the national CPR (light blue + dark blue), as it remained at 25%.
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user numbers among those who will maintain the organi-
sation’s previous year’s contribution to the CPR and
those new users who will be counted towards the percen-
tage point contribution to increasing CPR.
The Impact 2 model works at a micro level, an appropri-
ate approach given it is designed for use by service delivery
organisations. Impact 2 estimates the outcomes (e.g. unin-
tended pregnancies averted) for an individual who is using
family planning provided by a specific service delivery
organisation. It attempts to isolate the impact of individual
service delivery organisations, although it does not attempt
to show indirect population-level changes, such as reduc-
tions in the total fertility rate (TFR) or the maternal mor-
tality ratio (MMR).
Operating in Microsoft Excel, Impact 2 uses a user-
friendly interface that leads the user through each step of
the modelling process, from initial inputs to final outputs.
The model is run on one country (or region) at a time and
allows the user to look at any trend of the impact of family
planning services from 2001 to 2020.
Figure 2 Flowchart of model outputs estimated by Impact 2. a. The 40% pregnancy rate is a comparison rate reflecting the chance of
pregnancy had the women not been using contraception. b. Miscarriage estimates based on life tables of spontaneous abortion probabilities
created by Hammerslough (1993) [16]. c/d. National stillbirth rates used are from Cousens et al. (2011) [17]. e/f. National abortion ratios used
when published; otherwise, sub-regional ratios are used based on WHO and Guttmacher studies [12,18]. g. Methodology developed by
Population Services International to estimate the incremental effect of birth spacing from large sub-regional demographic health survey datasets
[19]. These estimates may be unreliable because data about the linkages between CPR, birth spacing, and child mortality are currently very
limited, and will be improved as more research becomes available in 2013. h. Maternal mortality ratio (MMR) is modelled to change overtime
based on several point estimates of MMR from WHO [13]. i. Disability-adjusted life years are calculated based on years of life lost (YLL) per each
maternal and child death, and years of life lost to disability (YLD) from maternal conditions, estimated by applying a sub-regional ratio of YLD/
YLL for maternal conditions [20]. j. Costs include supplies and direct labour only; default cost savings assume full coverage (i.e. all women who
need care receive it), and draw on regional cost and incidence data from the Reproductive Health Costing Tool [21].
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Note that the Impact 2 model produces results that
show how an organisation was responsible for adding
women to the national CPR. Because of the model’s
design, it does not consider if these women would have
otherwise had access to family planning services from
another provider. Thus, the results should be interpreted
as what the organisation contributed to increasing CPR,
but not how much lower the national CPR would have
been if the programme never existed.
Experts at Guttmacher Institute, Futures Institute,
Population Services International (PSI), International
Planned Parenthood Foundation, and London School of
Hygiene and Tropical Medicine have reviewed the
Impact 2 model. It is freely available for non-commer-
cial use at http://www.mariestopes.org/impact-2.
Theoretical basis for dividing user estimates between
baseline CPR levels and the contribution to increasing
modern CPR
In order for an organisation to contribute to increasing
the modern CPR, it cannot simply rely on counting ser-
vices provided to women who were not already using
contraception, called adopters. Increases are only realised
on top of maintaining an organisation’s baseline CPR
contribution from the previous year. Once this baseline
level is maintained, adopters can be counted towards
increasing CPR.
There are two components involved in maintaining a
baseline CPR contribution: 1) preserve the organisation’s
absolute number of users at baseline; and 2) reach addi-
tional users to offset population growth in those coun-
tries where populations are growing, a reality in most of
the developing world. Note that population growth
among women of reproductive age increases the abso-
lute number of users needed each year to maintain an
organisation’s baseline CPR contribution because CPR is
a proportional measure.
Women who are already using a contraceptive method
from an organisation, and continue to use a method
from the organisation, will count towards maintaining
the organisation’s baseline number of users. This princi-
ple also applies to women who decide to switch family
planning methods, provided they continue to obtain ser-
vices from the same organisation. Therefore, for each
year of interest, an estimate of the number of women
continuing to receive family planning services from the
organisation is needed. For users of long-term methods,
continuation is built into the model, so these estimates
already exist (Figure 3, a). However, because the model
is based on service provision data and not client-based
data, it cannot account for:
• Short-term users receiving services from the orga-
nisation who continue to use contraception in future
years (the model assumes that all discontinue at the
end of the year); or
• LAPM users obtaining services from the organisa-
tion who receive another method after discontinua-
tion (while service data will capture their resupply
method, the data will not show their previous family
planning method).
To address these shortcomings in the available data,
Impact 2 uses an estimate of the proportion of clients that
is continuing to receive services from the organisation as a
proxy for continuation in these two groups (Figure 3, b).
In some cases, once all continuation has been accounted
for, there can still be a gap between the number of conti-
nuing users and the number needed to maintain the pre-
vious year’s number (Figure 3, c). This gap exists because
some women may stop using family planning as they no
longer have a need for contraception, or, they might stop
visiting the service provider for other reasons. When this
gap occurs, adopters must fill it.
Once it is ensured that the previous year’s number of
family planning users is maintained, a portion, and some-
times all, of the adopters needs to be allocated to main-
taining the baseline CPR contribution in order to offset
population growth, if necessary (Figure 3, d). Only adop-
ters can be counted in this manner because the growth in
users must be among women not already counted in the
national CPR.
Finally, once all gaps in the baseline CPR level are filled,
any remaining adopters can be counted as contributors
towards increasing CPR (Figure 3, e). The model uses this
proportion when determining the service provider’s per-
centage point contribution to increasing modern CPR.
Note that Impact 2 cannot account for the family plan-
ning methods delivered by other service providers in a
country because the model is designed for use by a single
organisation. Therefore, in order for an organisation’s esti-
mated contribution to increasing CPR to translate into a
national-level increase, an assumption must be made that
all other providers maintain at least their baseline CPR
contributions. If not, an organisation’s estimated contribu-
tion to increasing CPR will help offset a decrease by
another provider instead. In addition, women who change
from another provider, called provider changers, do not
contribute towards maintaining an organisation’s baseline
level or towards increasing CPR, because the CPR already
included these women. This principle also applies to pro-
vider changers who switch methods, even more effective
ones such as a switch from a short-term method to an
LAPM. Impact 2 employs these principles in order to
address the substitution of clients, ensuring that service
delivery organisations are contributing to increasing CPR,
not claiming a CPR contribution created by another
organisation.
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Model inputs
Impact 2 determines an organisation’s impact on
increasing CPR and other health outcomes based on
various inputs. Service delivery data are the primary
input. Additional inputs include the organisation’s client
profile and a set of background data and assumptions
regarding national demographics and maternal health
outcomes, contraceptive methods used, and costs. As
with any modelling exercise, the quality of the input
data will dictate the quality of the results.
Service delivery data
The minimum data required to operate Impact 2 are an
organisation’s contraceptive service provision data by
method and year. The user must enter this data for all
years of interest. In addition, the model allows for historic
service provision data (dating back to 1982) to be input so
that an organisation can understand its impact over time,
an important model feature given that some women who
received services in the past may still be using the methods
during the period of interest. These historic data are used
to estimate the organisation’s baseline contribution to
increasing CPR, as discussed below. If these historic data
are not entered into the model, the organisation will not
be able to estimate an accurate baseline level.
Client profile
In order to account for substitution (i.e. existing modern
contraception users who are new to the organisation),
and effectively distribute users towards maintaining or
increasing an organisation’s CPR contribution, the
model relies on a client profile that divides an organisa-
tion’s clients from each year into three groups:
• % adopters: the proportion of clients who were not
using a modern family planning method before
receiving services (note: this includes women who
have used modern contraception in the past (ever-
use) but were not currently using before coming for
services);
• % continuers: the proportion of clients who were
already using a modern family planning method
which they had received from the service delivery
organisation; and
• % provider changers: the proportion of clients who
were existing modern family planning users and who
changed from a different provider to one affiliated
with the service delivery organisation of interest.
The organisation inputs this client profile into the
model, and can be based on client exit interviews or cli-
ent registration forms, or estimated based on project
design. More detailed guidance on how an organisation
can estimate its client profile can be found in the Impact
2 training materials available on the MSI website.
Background data and assumptions
Impact 2 relies on a series of data and assumptions to
model the organisation’s service data into the various
results. These data and assumptions include: national
trends (e.g. population projections, fertility rate projec-
tions), CPR data, mortality data (MMR, age-specific mor-
tality rates, unsafe abortion mortality), contraceptive
method-specific assumptions (e.g. typical-use failure
rates, median age of sterilisation), pregnancy outcomes
(e.g. miscarriage rates, abortion ratios), and cost savings
data (e.g. cost and incidence of pregnancy care and deliv-
ery). While any values can be entered into the model,
default data and assumptions have been pre-loaded for
all developing countries in order to improve the ease of
use. These default values are based on Demographic and
Figure 3 Illustration of the allocation of an organisation’s clients for determining its contribution towards increasing CPR.
Weinberger et al. BMC Public Health 2013, 13(Suppl 2):S5
http://www.biomedcentral.com/1471-2458/13/S2/S5
Page 6 of 17
Health Surveys (DHS) [10], United Nations (UN) Popula-
tion Prospects [11], World Health Organisation (WHO)
studies [12,13], and numerous other validated sources
(see Table 1 for sources of data referenced in this paper).
MSI updates these default data and assumptions annually
to ensure that Impact 2 models its outputs from the
most current sources available.
How the Impact 2 model operates
Determining estimates of users of long-term methods from
an organisation
To estimate the number of clients using a long-acting or
permanent method of family planning each year, Impact 2
creates virtual cohorts of users by method and year from
an organisation’s service provision data. Long-acting meth-
ods are implants and IUDs; permanent methods are male
and female sterilisation. To estimate continued use in sub-
sequent years, the model applies annual cumulative conti-
nuation rates (CCRs) (IUDs and implants) and mortality
rates (sterilisation) to these cohorts. For users of IUDs and
implants, the entire cohort is removed from the model
when the maximum duration of use is reached. Among
sterilisation users, removal occurs when the cohort is
no longer of reproductive age, which is assumed to be
49 years. For male sterilisation, note that the female part-
ner who is protected by the man’s sterilisation is counted
as the user because measures of contraceptive use are
based on women using contraception.
For each long-acting method m (10-year IUD, 5-year
IUD, 5-year implant, 4-year implant, 3-year implant), the
number of users in the cohort created in year y is calcu-
lated for each year (n = 0 to n = maximum duration of
the method):





where CCRn is the cumulative continuation rate in
year n for the specified method. Note that CCR0 = 1,
since all women are using the method at the time of
insertion.
For male and female sterilisation, the number of users
in the cohort created in year y is calculated for each
year (n = 0 to n = cohort reaches age 49), by applying
the estimated probability of survival from one year into
the next. Survival probabilities are not cumulative,
meaning that the survival rate is applied to the previous
year’s user estimate, rather than the original number of
male and female sterilisation clients in year y:






where 5px is the probability of survival between ages x
and x+5 for the age group that contains the median age
of the cohort. The median age of the cohort is set to
begin at the median age of sterilisation, which then
increases by one year for each subsequent year. The
probability of survival is raised to the one-fifth to reflect
the probability of survival over one year rather than
across the standard five-year interval for survival prob-
abilities, assuming an even distribution of survival across
the age group. The value of 5px is determined based on
a country’s assigned model life table family [14] and the
projected life expectancy at birth (ex) in year y+n. When
determining which model life table to use, MSI applies
results from its own analyses to assign each country
into one of nine model life table families: Coale-Demeny
(CD) East, CD North, CD South, CD West, UN Chilean,
UN Far East Asian, UN General, UN Latin, and UN
South Asian.
Once the number of users for each cohort has been
determined, Impact 2 calculates the estimated number
of LAPM users in any given year by totalling the figures
for each cohort (Figure 4).
Determining estimates of users of short-term methods
from an organisation
Short-term family planning methods are those contracep-
tive methods that require multiple commodities for one
year of coverage, such as oral contraceptive pills, con-
doms, and injectables. For these methods, virtual cohorts
are not needed because services provided in one year do
not provide protection beyond that year. Therefore, all
short-term method users are counted in an organisation’s
annual service provision data for the subsequent years of
use, even if a woman continues to use a short-term
method from year to year.
Table 1 Sources of relevant default assumptions in Impact 2 model
Data Source
Projected women of reproductive age UN Population Prospects (2010) revision [11]
Projected female life expectancy at birth (e0) UN Population Prospects (2010) revision [11]
Female age-specific mortality rates (5px) Model life table families [14]
Units needed for one year of coverage United States Agency for International Development (USAID) 2011 CYP Update [6]
Median age of sterilisation DHS (for samples greater than 30 women) or weighted regional average [10]
Cumulative continuation rates (IUD, implant) USAID 2011 CYP Update [6]
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The type of data collected by most service delivery
organisations makes the estimation of short-term users
difficult, however. In general, providers collect data on
the number of commodities provided (e.g. number of
contraceptive pill cycles) rather than the number of cli-
ents served. For instance, while an organisation’s data
might show the distribution of 13 pill cycles (the number
needed for a full year of coverage), it is unknown if 13
different women each received one cycle of pills, if one
woman received a full year’s worth of pills, or if a differ-
ent distribution was provided. Tracking client numbers
requires a client-based management information system
that can link multiple visits in a year to a single client, a
system that is beyond the resources of most family plan-
ning providers in the developing world.
Despite these shortcomings with the data, it is possible
to estimate the number of users of short-term methods.
The ultimate aim is to derive an estimate of a method’s
users that is comparable to measures of CPR, which are
determined by data from national population surveys,
such as DHS. These surveys have their own limitations,
however. DHS data capture contraceptive use at a single
point in time over a given year, with ‘current use’ defined
by the respondent [15]. Depending on when the survey is
undertaken and how the potential pill clients (anywhere
from 1 to 13 clients) are distributed across the year (i.e.
consecutively versus concurrently), it is possible for a sur-
vey to detect all or none of them.
For this reason, the Impact 2 model takes a conservative
approach, counting ‘users’ as having full coverage for the
entire year. Thus, in the preceding example, the 13 pill
cycles are attributed to a single contraceptive pill user over
the course of the year. Assuming even distribution of use
across the year, the estimated number of pill users
captured by the organisation’s service delivery data should
accurately reflect the user numbers captured in the CPR.
If use were actually skewed (e.g. multiple clients who
simultaneously take one cycle of pills each), the user esti-
mates may not accurately reflect the same pill use cap-
tured by the CPR.
Therefore, Impact 2 estimates the number of short-
term method users for each method m as follows:




Units needed for 1 year of coveragem
The number of units needed for one year of contra-
ceptive coverage represents the number of commodities
needed. This number is similar to the one used to calcu-
late couple-years of protection (CYP) [6], but it is not
identical because method failure rates are not included.
Impact 2 accounts for method failure when estimating
unintended pregnancies to users. It should be noted that
Impact 2 assumes that short-term user estimates refer to
clients who use the short-term contraceptive methods
according to the general usage patterns applied by
USAID when calculating CYP factors [6]. Inconsistent
use that may lead to method failure is accounted for
elsewhere in the model, when method-specific failure
rates are applied to estimate unintended pregnancies
averted (not covered in this paper).
Determining an organisation’s contribution to increasing
modern CPR
This section describes each of the calculations underta-
ken by Impact 2 to estimate an organisation’s contribu-
tion towards increasing modern CPR. It is explained in a
series of steps.
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
1999 a a a a a a a a a a a a a
2000 b b b b b b b b b b b b
2001 c c c c c c c c c c c
2002 d d d d d d d d d d
2003 e e e e e e e e e
2004 f f f f f f f f
2005 g g g g g g g
2006 h h h h h h
2007 i i i i i
2008 j j j j
2009 k k k
2010 l l
2011 m
Figure 4 Illustrative example of determining cohorts of LAPM users. Impact 2 creates a matrix such as the one above for each LAPM used
by a client of the organisation. Each row represents the cohort that corresponds to the year in which the method was delivered. For example,
‘a’ denotes the cohort provided contraceptive services in 1999. This cohort ‘a’ is shown in subsequent years to represent the users’ continuation
with their LAPM in future years. To estimate the total number of LAPM users of a long-acting and permanent method in any given year, the
numbers associated with the column of the year of interest are totalled, as shown by the pink box surrounding the cohorts listed in 2005. In
actuality, the model accounts for cohorts starting from services provided in 1982 to capture all continuation of LAPMs from 2001 (the first year
of analysis included in the model) onwards.
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1. Establish a baseline CPR contribution from the
previous year An organisation’s baseline contribution to
CPR is calculated in terms of its absolute contribution
(i.e. baseline user numbers) and relative contribution
(i.e. baseline CPR contribution which accounts for popu-
lation growth offsets). Both are based on its contribu-
tions in the baseline year (y0), which is the year before
the selected trend starts. For example, a trend from
2005 to 2010 is measured against a 2004 baseline.
The number of baseline users counts all users in the
baseline year, using the methodology described above
for modelling service provision data into estimates of
LAPM and short-term method users. The baseline esti-
mate is made from historic service provision data, which
the service delivery organisation must input into the
model:
Baseline users = Total number of usersy0
To estimate the baseline CPR contribution, divide the
total estimated number of users in the baseline year by the
projected number of women of reproductive age in the
same year. If the survey-based CPR estimates entered into
the model are based on all women, then, the full WRA
number is used; otherwise, if the CPR estimates are for
married or cohabitating women (hereafter referred to as
‘in-union’), then the WRA is multiplied by the estimated
proportion of women in union:
Baseline CPR contribution =
Total number of usersy0
Number of (WRA or in-union WRA)y0
2. Account for pre-existing LAPM users Pre-existing
users are the estimated number of LAPM users each year
that had received LAPM services before the year of inter-
est (i.e. baseline year and before). These numbers are cal-
culated by method and year from the virtual cohorts of
LAPM users created in the baseline year as well as in the
years prior to baseline for which service provision data
were entered. The total number of women estimated to
still be using the long-term method during each year of
the trend (y1 to yn) is summed across each cohort (see
Figure 4 above).
3. Calculate the number of new users created each year
from all family planning methods The service provision
data entered for the years covered by the trend (y1 to yn)
are converted into the estimated number of new users
created the year the services are provided, for both
LAPMs and short-term methods. To calculate this num-
ber, Impact 2 follows a similar methodology to that
described above for determining estimates of short-term
and long-term users. However, the model only calculates
estimates of LAPM users for the first year. Note that the
number of first-year LAPM users will be slightly fewer
than the number of clients served in the first year
because some women may die, and some women may
discontinue the method before the end of the first year.
Below are the formulas that Impact 2 uses for each type
of contraceptive method:
• For each long-acting method m (10-year IUD,
5-year IUD, 5-year implant, 4-year implant, 3-year






where CCRn is the cumulative continuation rate in
year n for the specified long-term method. Note that
CCR0 = 1, since all women are using the method at the
time of insertion.
• For male and female sterilisation, the number of
users created in year y is calculated as follows:







where 5px is the probability of survival between ages x
and x+5 for the age group that contains the median age
of sterilisation. See above for the source for calculating
5px.
• For each of the short-term methods, user numbers
are calculated by dividing the number of services
provided by the number of units needed for one




Units needed for 1 year of coveragem
4. Distribute first-year users between maintaining
baseline and increasing user numbers First, Impact 2
makes an estimate of the total number of users needed
to maintain the baseline number of users:
Users needed to maintainy1 = Baseline users - Pre-existing usersy1
Then, the model checks to see how the new users
should be distributed, based on the numbers needed and
the client profile. To do so, the model initially calculates
the total number of new users who will be apportioned as
continuers and adopters:
New continuersy1 = New usersy1 ×% continuersy1
New adoptersy1 = New usersy1×% adoptersy1
There are three possible situations in this apportionment:
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Situation 1: There are enough new continuers to
maintain the baseline contribution, and therefore, all
adopters are allocated to increasing user numbers;
Situation 2: There are not enough new continuers or
adopters to maintain the baseline contribution, and
therefore, all continuers and adopters are allocated to
maintaining baseline levels, with the number of users
actually decreasing from the baseline contribution; and
Situation 3: There are not enough new continuers to
maintain the baseline number, and therefore, some
adopters are allocated to maintaining the baseline con-
tribution, with the remaining adopters allotted to
increasing user numbers.
The model checks to see which situation is occurring,
then distributes new users accordingly, into two groups:
Maintain usersy1 = New users that maintain the baseline user numbery1
Increase usersy1 = New users that increase numbers above the baseline levely1
For situation 1, all adopters are allotted to increasing
user numbers, therefore:
Maintain usersy1 = Baseline users - Pre-existing usersy1
Increase usersy1 = New adoptersy1
For situation 2, all adopters are allocated to maintain-
ing the baseline user number, resulting in:
Maintain usersy1 = New adoptersy1 + New continuersy1
Increase usersy1 = 0
For situation 3, some adopters will be allocated to
both maintaining the baseline user number and increas-
ing user numbers above baseline, so:
Maintain usersy1 = Baseline users - Pre-existing usersy1
Increase usersy1 = New adoptersy1
-
[
Baseline users - Pre-existing usersy1 - New continuersy1
]
5. Calculate the proportion of new users counting
towards CPR in the first year Now, Impact 2 esti-
mates the proportion of all new users counting towards
CPR in the first year. To do so, the number of users
maintaining the baseline contribution and the number
of users above the baseline level are divided by the
total number of new users created in the first year.
Therefore:
% counting in CPRy1 =
Maintain usersy1 + Increase usersy1
New usersy1
This proportion is applied to the number of new users
of each method m to estimate the number of users of
each method that contributes to a CPR increase:
New CPR usersmy1 = % counting in CPRy1 ×New usersmy1
6. Calculate the number of LAPM users who will con-
tinue the method in subsequent years Once the number
of new users who count towards CPR is determined, an
additional step must be taken for the new LAPM users
counting in the CPR. For these users, an estimate is
needed of how many will still continue to use their
LAPM in each subsequent year left in the trend. These
users are referred to as ‘existing users’, which are differ-
ent from pre-existing users (who were provided services
before the first year of the trend). To determine the num-
ber of these existing users, Impact 2 follows the metho-
dology described earlier for calculating estimates of long-
term users. Thus, for each LAPM method m, the virtual
cohort of users will be followed, applying the correspond-
ing continuation rates (based on year) and mortality rates
(based on age of cohort and life expectancy) each year.
Note that there are not any existing users in the first
year (y1). All clients who receive services are counted as
new users, and any past clients who continue to use
their LAPM are counted as pre-existing users.
7. Repeat this procedure (steps 1-6) for the remaining
years in the trend Impact 2 repeats this process for each
remaining year in the trend. However, rather than mea-
suring against the baseline year, calculations are based on
the year immediately prior to the year of interest. For
example, the second year in the trend (y2) measures
increases against the total number of users contributing
to CPR in the first year (y1).
The total number of users contributing to a CPR
increase in a given year (yz) is calculated as follows:
Total users in CPRyz = Pre-existing usersyz
+ Existing usersyz + Maintain usersyz + Increase usersyz
Once the total number of users in the CPR in year yz
is known, the number of users needed to maintain this
number of total users in the CPR in the following year
(yz+1) can be calculated using the following:
Users needed to maintainyz+1 = Total users in CPRyz
- Pre-existing usersyz+1 - Existing usersyz+1
As described above in step 4, allocation of new users
is based on the three scenarios for continuers and adop-
ters. Thus, new users are distributed accordingly into:
Maintain usersyz+1 = New users to maintain the previous year’s number
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Increase usersyz+1 = New users that increase the previous year’s number
Next, as described above in step 5, the percentage of
new users, of both long-term and short-term methods,
that contributes to an organisation’s CPR increase is
estimated. As noted in step 6, the proportion of LAPM
users must be input into virtual cohorts, which are
traced out to estimate the number of existing users in
each of the trend’s remaining years. This iterative pro-
cess is continued for each successive year, until the end
of the trend is reached.
8. Produce the model output: the percentage point
contribution to increasing CPR The final Impact 2 out-
put described in this paper is an organisation’s estimated
percentage point contribution to increasing modern
CPR. In other words, this figure is an estimate of how
much a service delivery organisation has, or will,
increase the national CPR from its baseline contribution,
assuming all other providers at least maintain their
baseline contributions.
To estimate this figure, an organisation’s total percen-
tage point contribution to increasing CPR is calculated
for each year first. To do so, Impact 2 divides the total
number of users counting in CPR each year (total users
in CPR in year yz) by the number of WRA in each year
(or in-union WRA if the CPR of only in-union WRA is
selected):
Total % point contributionyz =
Total users in CPRyz
Number of (WRA or in-union WRA)yz
This calculation’s result includes the organisation’s
baseline percentage point contribution to CPR (since
those users who maintain the baseline level are included
in the total number of users counting in CPR). Therefore,
to isolate the proportion contributing only to increasing
CPR, the baseline percentage point contribution must be
subtracted:
% point contribution to increasing CPRyz = Total % point contributionyz
- Baseline CPR contributiony0
Results
Actual results from Impact 2 are instructive for demon-
strating how the model operates. Service provision data
and a client profile from MSI’s field office in Madagascar,
Marie Stopes Madagascar, were fed into Impact 2 to esti-
mate user numbers and determine the organisation’s
contribution to increasing modern CPR. Marie Stopes
Madagascar has been providing reproductive health
services in this sub-Saharan African country since the
mid-1990s. In 2011, Marie Stopes Madagascar delivered
services through 15 clinics, 12 outreach teams, and 133
social franchise outlets.
Additional file 1 shows Marie Stopes Madagascar’s
service provision data from 1996-2010. In addition, the
following client profile was used for all years, based on
unpublished data from client exit interviews that MSI
conducted with 438 randomly selected clients in 2011:
• % adopters = 22.4%
• % continuers = 49.2%
• % provider changers = 28.4%
Using the data in Additional file 1 as well as the
default assumptions preloaded into the model for Mada-
gascar, Impact 2 calculated the trends of user numbers
and CPR increases from 2005 to 2011. Condom users
were excluded from the calculations to avoid the risk of
overestimating condom use because of user wastage and
dual protection (using condoms and another contracep-
tive method). MSI generally recommends that research-
ers and programmers calculate contributions to
increasing CPR without condom use included.
In 2011, an estimated 200,000 women were using a con-
traceptive method provided by Marie Stopes Madagascar,
with nearly 90% of these women using a LAPM (Table 2).
From 2005-2011, Marie Stopes Madagascar steadily
increased its family planning service provision, with the
estimated number of all users increasing eightfold. The
number of new adopters contributing to increasing CPR
rose accordingly, also increasing eight times within this
same time period. The number of adopters increasing
CPR was slightly smaller than the total number of adop-
ters served during each year of interest because some
adopters are allocated to maintaining the previous year’s
(or baseline) CPR contribution. Table 2 shows a complete
breakdown of the model estimates for different categories
of users by year.
Following the methodology described above, Impact 2
calculated the 2005-2011 baseline CPR and increasing
CPR contributions from these estimated user numbers.
The baseline CPR contribution was estimated to be 0.5%
points; in other words, in 2004, Marie Stopes Madagascar
provided contraceptive methods to 0.5% of women of
reproductive age. Beyond maintaining this baseline CPR
contribution, Marie Stopes Madagascar is estimated to
have contributed 1.2% points towards increasing the
national modern CPR from 2005-2011. Due to the design
of the model, this result can only be interpreted as an
increase if the assumption that all other providers at least
maintained their baseline (i.e. 2004) CPR contributions is
true.
To show the important role of the client profile in esti-
mating CPR increases, the percentage point increase to
modern CPR was recalculated based on two different cli-
ent profiles: one with a lower percentage of adopters and
one with a higher percentage of adopters than the actual
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client profile determined from exit interviews conducted
in 2011. Running these different scenarios in Impact 2 is
important when data for each year of interest are unavail-
able. In this case, Marie Stopes Madagascar only had exit
interview data from 2011, so the client profile from this
year needed to serve as a proxy for the other years in the
trend (2005-2010). As it is unlikely that the 2011 client
profile accurately applied to these years, it is useful to
input different client profiles to model a range of possible
results. As shown in Figure 5, the client profile with the
highest proportion of adopters yielded considerably higher
estimates of the percentage point contribution to increas-
ing CPR.
To illustrate the importance of accounting for conti-
nuation among LAPM users from year to year and not
merely relying on service provision data, Figure 6 shows
the difference between the number of women served
with long-term methods and the estimated LAPM user
numbers modelled by Impact 2. The modelled numbers
are more than double those tracked by Marie Stopes
Madagascar’s service provision data because Impact 2
accounts for continuers when determining its estimates
for users of long-term methods.
Discussion
The Impact 2 model offers some important advantages
for modelling a service delivery organisation’s health
impact in a country as the example from Marie Stopes
Madagascar demonstrates. Namely, these results show
that Impact 2’s outputs can provide a service delivery
organisation with a better understanding of its indivi-
dual contribution to national CPR. Instead of relying on
service provision data or CYPs that can misrepresent
programme impact, an organisation can use Impact 2
estimates to gain a more accurate picture of the results
of its efforts. These estimates also provide a more
nuanced understanding of how whom an organisation
reaches can greatly influence outcomes.
Table 2 Estimated number of women using family planning services from Marie Stopes Madagascar, 2005-2011, by
type of user (excluding condoms)
2005 2006 2007 2008 2009 2010 2011
Total users 26,244 33,525 46,255 55,550 83,317 141,038 197,860
LAPM users 14,105 21,371 31,636 44,109 73,427 123,768 175,283
Short-term method users 12,139 12,154 14,619 11,442 9,890 17,270 22,577
Users served each year 17,617 20,387 26,273 25,708 41,861 73,315 85,573
Adopters served each year 3,945 4,566 5,884 5,757 9,375 16,419 19,164














































Figure 5 Range of Marie Stopes Madagascar’s estimated contribution to increasing CPR, 2005-2011, based on different client profiles
(excluding condoms). Marie Stopes Madagascar’s estimated percentage point contribution to increasing modern CPR from 2005-2011 changes,
depending upon the client profile input into the Impact 2 model. The middle line (blue) shows the model outputs based on the actual profile
determined by 2011 exit interviews: 22% adopters, 49% continuers, and 28% provider changers. The bottom line (grey) displays results based on
a lower percentage of adopters in the profile: 11% adopters, 61% continuers, and 28% provider changers. The top line (fuschia) shows the
model estimates based on a higher percentage of adopters in the profile: 44% adopters, 28% continuers, and 28% provider changers.
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As shown, estimates of increasing CPR generated by
Impact 2 isolate the contribution of an individual service
delivery organisation, a process that other family planning
models do not currently offer. With Impact 2, an organisa-
tion can better attribute CPR changes to its specific pro-
gramme efforts. Moreover, because the analyses can look
retrospectively, any CPR increase can be benchmarked
against actual DHS data, obviating the need for the
assumption that all other providers at least maintained
their baseline CPR contributions. Through these compari-
sons, an organisation can interpret its programme impact
on increasing CPR with reasonable certainty, given the
organisation is confident in its client profile data. For
example, in the Madagascar case described above, DHS
data show modern CPR increasing from 14% in 2004 to
23% in 2009 [10]. Thus, assuming the client profile is
accurate, Impact 2 results indicate that Marie Stopes
Madagascar’s service provision contributed around 4% of
the growth in the CPR.
Besides isolating a specific organisation’s impact, mod-
elling user numbers with Impact 2 results in richer data
about programme reach and more robust information
about programme impacts than measures in current
use, such as standard service provision data and CYPs.
As shown in Figure 6, the overall number of LAPM
users increases at a much faster rate than scale up of
service provision due to the continuation of LAPM
users from year to year. In 2011, for example, Marie
Stopes Madagascar recorded the delivery of 67,111
LAPM services (Additional file 1), a much smaller figure
than the 175,283 LAPM users that Impact 2 estimated
for that year (Table 2). Thus, if an organisation relies
solely on annual service provision totals for understand-
ing programme impact, it can underestimate the
number of users it serves, resulting in lower impact esti-
mates. While CYPs are able to account for differences
in usage duration of a contraceptive method, the total
number of CYPs delivered in a year by a service organi-
sation cannot be compared to annual impact measures
such as increasing CPR. The reason why this compari-
son cannot be made is because CYPs are realised over
an undefined number of future years, and therefore, this
metric cannot be determined on an annual basis. Impact
2 has the added advantage of creating annual figures
that holistically capture the full impact of an organisa-
tion’s service provision (e.g. number of pregnancies
averted, number of family planning users).
An organisation can also overstate its contribution to
national-level changes if it simply looks at its total esti-
mated user numbers, without accounting for substitu-
tion, as well as the dynamics of population growth and
CPR changes. Impact 2 needed to discount a proportion
of Marie Stopes Madagascar’s estimated users from
2005-2011 to account for substitution, and allocate the
majority of the remaining users to maintaining the base-
line CPR contribution. In each of these years, only
about 10% of the organisation’s estimated users were
considered as contributors to increasing CPR. If the
total increase in users from 2005 to 2011, nearly
200,000 women, was attributed to increasing CPR,
Marie Stopes Madagascar would have grossly overstated
its program’s contribution to increasing CPR. Using
Impact 2 helps curb any unrealistic claims of impact.
The results above also underscore the importance of
reaching adopters if an organisation wishes to have a mea-
surable impact on increasing CPR. As explained, only
adopters are able to contribute to increasing CPR. Figure 5
demonstrates how increases in the proportion of adopters
2005 2006 2007 2008 2009 2010 2011
Users 14105.5 21370.68 31636.14 44108.5 73427.3 123767.5 175282.8




















Figure 6 Comparison of modelled LAPM user numbers with LAPM services provided each year, Marie Stopes Madagascar, 2005-2011.
The number of estimated LAPM users served by Marie Stopes Madagascar is considerably larger than the number of LAPM services tracked in
its service provision data during a given year. The blue bars represent the number of women that Impact 2 modelled as using a LAPM method
from Marie Stopes Madagascar in each year. Included in these estimates are pre-existing users of LAPMs who are modelled to still be using the
method in the year of interest. The grey bars show the number of LAPM services provided each year to Marie Stopes Madagascar clients. These
service provision data do not recognize continuation among users, something Impact 2 takes into account.
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in the client profile can dramatically affect the estimated
percentage point contribution to increasing modern CPR.
For example, if Marie Stopes Madagascar reached twice as
many adopters, contribution to increasing CPR would be
nearly doubled. However, these results also demonstrate
that reaching adopters alone will not translate into CPR
increases. As shown in Table 2, not all adopters served by
Marie Stopes Madagascar contribute to increasing CPR.
Impact 2 must account for maintaining a proportional
contribution (i.e. percentage of WRA using a method
from the provider), meaning some, if not all, adopters
must go towards offsetting population growth. Moreover,
the model recognises that some existing users will discon-
tinue and need to be replaced by new adopters. Approxi-
mately 14% of the adopters from 2005-2011 had to be
allocated towards maintaining a baseline contribution
from the previous year. Therefore, it is essential for service
delivery organisations to concentrate programming efforts
on continuing to provide services to existing users as well
as reaching adopters, to ensure that the maximum number
of adopters is counted towards increasing modern CPR.
The importance of maintaining this existing contribution
should not be underestimated, especially in rapidly grow-
ing countries where much scale up is needed just to keep
up with population growth.
Limitations
While Impact 2 has made large improvements in how ser-
vice delivery organisations are able to consider their health
impact, they are still only modelled estimates, which are
inevitably imprecise. Where applicable, the most
conservative approach available was taken to minimize
overstating results. A summary of key limitations is pre-
sented in Table 3, with additional discussion in the subse-
quent paragraphs. It is useful to separate limitations due
to the quality of the input data from those inherent to the
model design.
As an organisation’s service provision data are the pri-
mary driver of Impact 2 results, inputting accurate data is
critical for avoiding the inflation of user estimates. There-
fore, the service data entered into the model must reflect
only the services and commodities that reach clients. To
do so, data collection systems need to be built with
mechanisms that ensure the quality and accuracy of their
data, an important underlying principle of all service data
collection, not just for Impact 2 modelling. In cases where
an organisation only operates in supply chain stages before
the direct provision to clients (e.g. procuring contracep-
tives or selling contraceptives to pharmacies), a discount
factor may need to be added to account for commodity
wastage. In this situation, attribution must also be consid-
ered to avoid double counting.
The client profile presents another key data input chal-
lenge for the ‘increasing CPR’ metric as the methodology
for estimating CPR increases is very dependent on this
profile. As noted earlier, if data are not available for all
years of interest, one year’s profile is used as a proxy for
the other years. Doing so is likely to produce inaccurate
results because client profiles are expected to change from
year to year. In addition, how client profile data are col-
lected is likely to influence results (e.g. exit interviews that
ask about contraceptive use in the past three months,
Table 3 Summary of key limitations related to data inputs and model methodology
Area Limitation Ability to minimize
Data-related limitations
Service provision data Service data must reflect services provided directly to
clients; potential challenges include ensuring data
quality, and inflation when counting commodities
further back in supply chain.
Model is best positioned to be used by organisations
delivering services directly to clients. Organisations
should ensure their data accurately reflect services
provided.
Client profile data High potential to over- or underestimate CPR
contribution depending on accuracy of client profile
data.





Limited potential to over- or underestimate results. Best available data have been pre-loaded, with potential
error minimised as much as possible.
Model methodology-related limitations
Converting services to short-
term users
Potential to either over- or underestimate number of
users due to uncertainty around how many of the
delivered short-term commodities are actually used.
For coitus-based methods, there are limited data on
units needed in a year, and the potential that dual
protection double counts users.
Remove condom users from calculations to reduce
greatest uncertainty. For pills and injectables, the
approach minimises overestimation as much as possible
given current data on consistency of use.
Treatment of provider changers Potential to underestimate increases in CPR as model
assumes provider changers are not replaced, and that
women leaving the organisation (e.g. women who
stop using contraceptives) are not counted in the CPR.
High and low estimates created based on alternative
client profiles.
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versus a routine data system). Guidance on developing cli-
ent profiles is available on MSI’s website. These caveats
underscore the importance of re-running the model with
different client profiles to understand how its outputs
change, as shown above in Figure 5.
Another potential shortfall is the model’s treatment of
provider changers, women who had used a family planning
method previously and changed service providers. When
estimating CPR increases, these women are excluded
because the model sees changing providers as taking mar-
ket share from another provider rather than growing the
market. In reality however, there may be a complex
exchange between providers. Because the model only
accounts for one organisation, it is unable to determine if
provider changers were replaced by their previous provi-
der, or if clients who left the organisation went elsewhere
or simply stopped using contraceptives. The model
assumes the most conservative scenario in that all ‘provi-
der changers’ would have continued to receive family plan-
ning services anyway and that all clients who leave the
organisation have stopped using contraceptives. This
assumption means that the model is likely to underesti-
mate an organisation’s contribution to increasing CPR.
There are situations where these assumptions do not hold
and it may require a revision of the client profile used in
the model. For example, if the previous provider has shut
down, these women may have stopped using contracep-
tives (and therefore, dropped out of the CPR) had they not
changed providers. In this case, the organisation may wish
to count these clients towards maintaining a CPR contri-
bution, rather than excluding them altogether. To do so,
the organisation can edit the client profile, with a propor-
tion of the provider changers added to the proportion of
continuers.
Impact 2’s reliance on demographic projections from the
United Nations on fertility rates (e.g. Total Fertility Rate)
and demographics (e.g. WRA) may also be viewed by
some as a limitation. Due to the use of these data, the
model is unable to account for a dynamic relationship
between increased contraceptive use, fertility rates, popu-
lation growth, and age structure. However, because Impact
2 works on a relatively short time frame, the projected
WRA population used to estimate CPR contributions will
not be affected by short-term changes in the CPR and
TFR, due to a lag between the emergence of smaller birth
cohorts and the time when these cohorts reach reproduc-
tive age. Therefore, the micro level results from this model
are still useful and relevant.
One important limitation of the increasing CPR metric
itself is that because a woman is counted in the modern
CPR no matter what contraceptive method she uses, the
metric does not reflect any added benefit of existing
users switching to more effective methods. Furthermore,
in some cases, these switchers are fully excluded from
the increasing CPR calculation, despite making this
important change in method, because of the substitution
effect. For example, a method switcher who changes pro-
viders in order to acquire the new method is not counted
as part of the organisation’s contribution to increasing
CPR. While not captured within the increasing CPR
metric, Impact 2 is capable of modelling the differential
health impacts that result from the use of more effective
family planning methods. Other Impact 2 model outputs,
such as unintended pregnancies averted, factor in
method switchers who opt for more effective methods.
Future publications on the Impact 2 model will discuss
these benefits.
Finally, many other benefits of providing family plan-
ning services are challenging, if not impossible, for
Impact 2 to quantify. For example, the model cannot
easily assess the role that service quality plays in discon-
tinuation rates and method failure rates. Quantitative
data also cannot describe how improved birth spacing
enhances a mother’s and a family’s well-being, or what
structural barriers exist in the country to prevent
women from accessing the contraceptive services they
need. Therefore, results from Impact 2 should always be
placed within the national context, and supplemented
with additional data from qualitative studies and other
sources.
Conclusion
With Marie Stopes International’s Impact 2 model, ser-
vice delivery organisations are better equipped to plan
for and demonstrate their progress towards key global
health goals, such as reducing the unmet need for family
planning. By considering health impact from the per-
spective of an individual service delivery organisation,
Impact 2 fills the gap not met by other models for
family planning service outcomes. With this model, an
organisation’s service provision data can be converted
into more useful measures of impact than simply count-
ing the number of services and commodities provided,
the number of clients served, or the number of couple-
years of protection afforded. It does so while accounting
for complex issues germane to family planning service
delivery and essential to consider when developing effec-
tive metrics to measure impact:
• First, maintaining the existing CPR cannot be over-
looked when estimating a service delivery organisa-
tion’s contribution to increasing national CPR.
Metrics that only look at adopters reached, without
accounting for the nuances of population growth and
maintenance of previous usage levels, will not fully
capture the impact of services on changing CPR.
• Second, the model stresses the importance of
accounting for substitution, i.e. providing services to
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women who were already using family planning ser-
vices from another source. While a scale up in ser-
vice delivery numbers will translate to a scale up in
total impacts, this increase may not transfer into lar-
ger national contributions, however. Metrics that
only capture scale (such as service provision num-
bers or CYPs) are unable to address substitution.
• Last, the model incorporates the issue of continua-
tion among LAPM users into an annual output mea-
surement. Metrics that only consider clients served
within the raw data’s year of interest do not fully
capture program impact in that year.
Thus, MSI’s Impact 2 methodology allows organisa-
tions to move beyond cruder output measures to a bet-
ter understanding of the role they play in the countries
where they work.
Impact 2 also offers users the opportunity to model a
wide range of results, of which percentage point contribu-
tion to increasing modern CPR is just one. While not dis-
cussed in this paper, Impact 2 is capable of producing a
series of metrics related to the estimated health, demo-
graphic, and economic impacts of family planning services
that are recognized as standards by the global health com-
munity. Such results are useful within many different con-
texts, including programme and policy advocacy,
communications with governments and donors, and mon-
itoring programme progress over time. Moreover, Impact
2 enables both retrospective and prospective modelling, a
capability that empowers organisations with informed
decision making and more realistic programme planning.
Impact 2 results can also play an important role in
improving service delivery. The model structure and the
estimates produced highlight the need for an organisation
to carefully consider whom it is reaching (e.g. adopters,
provider changers). Doing so ensures that its programme
is playing a role in growing the market, not just increasing
user numbers. As service providers answer the recent call
to address the large unmet need for family planning
worldwide, knowledge of how to accurately measure this
expansion will be indispensable.
Additional material
Additional file 1: Service provision data from Marie Stopes Madagascar,
1996-2011, by numbers of commodities/services provided by method.
These data show how many family planning commodities and services
Marie Stopes Madagascar provided to clients from 1996-2011. They are
organised by method.
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